ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010